Sysucc.org.cn - Sun Yat-sen University Cancer Center - SYSUCC

Provided by Alexa ranking, sysucc.org.cn has ranked N/A in N/A and 3,470,909 on the world. sysucc.org.cn reaches roughly 893 users per day and delivers about 26,803 users each month. The domain sysucc.org.cn uses a Commercial suffix and it's server(s) are located in N/A with the IP number 14.18.110.149 and it is a .org.cn domain.

WEBJan 17, 2022 · Sun Yat-sen University Cancer Center (SYSUCC) was established in 1964 and is one of the four earliest tumor hospitals in China. It is one of the affiliated hospitals of the prestigious Sun Yat-sen University. Located in the city of Guangzhou, SYSUCC is leading the way on a national frontier.

List of domain same IP 14.18.110.149

Search Results related to sysucc.org.cn on Search Engine

Sun Yat-sen University Cancer Center - SYSUCC
sysucc.org.cn

https://english.sysucc.org.cn/

WEBJan 17, 2022 · Sun Yat-sen University Cancer Center (SYSUCC) was established in 1964 and is one of the four earliest tumor hospitals in China. It is one of the affiliated hospitals of the prestigious Sun Yat-sen University. Located in the city of Guangzhou, SYSUCC is leading the way on a national frontier.

DA: 64 PA: 56 MOZ Rank: 95

Effect of Capecitabine Maintenance Therapy Using Lower Dosage …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729589/

WEBJan 1, 2021 · In this randomized clinical trial of 434 women with early-stage triple-negative breast cancer who received standard adjuvant treatment, low-dose capecitabine maintenance therapy for 1 year, compared with observation, resulted in significantly higher 5-year disease-free survival (82.8% vs 73.0%; hazard ratio for risk of recurrence or death, 0.64).

DA: 33 PA: 85 MOZ Rank: 61

Sun Yat-sen University Cancer Center
sysucc.org.cn

https://english.sysucc.org.cn/index_49.aspx

WEBLocated in the city of Guangzhou, SYSUCC is leading the way on a national frontier. It is the largest integrated cancer center in the whole of southern China for cancer care, education, research and prevention. SYSUCC’s mission is to help people prevent and cure cancer.

DA: 58 PA: 36 MOZ Rank: 36

Effect of Capecitabine Maintenance Therapy Using Lower Dosage …
jamanetwork.com

https://jamanetwork.com/journals/jama/fullarticle/2774295

WEBEffect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial | Breast Cancer | JAMA | JAMA Network. P. a. b. c. Table 1.

DA: 19 PA: 25 MOZ Rank: 9

Phase III trial of metronomic capecitabine maintenance after standard …
ascopubs.org

https://ascopubs.org/doi/10.1200/JCO.2020.38.15_suppl.507

WEBMay 25, 2020 · Phase III trial of metronomic capecitabine maintenance after standard treatment in operable triple-negative breast cancer (SYSUCC-001). | Journal of Clinical Oncology. Free access. Breast Cancer—Local/Regional/Adjuvant. May 25, 2020.

DA: 22 PA: 3 MOZ Rank: 67

Sun Yat-sen University Cancer Center
sysucc.org.cn

https://english.sysucc.org.cn/index_17.aspx

WEBSun Yat-sen University Cancer Center. About Us. SYSUCC. 1964. 1970s. 1980s. 1990s. 2000s. 2010s. Welcome. This timeline provides a glimpse into the history and development of Sun Yat-sen Cancer Center from a small hospital to the modern cancer center it is today.

DA: 38 PA: 17 MOZ Rank: 61

Sun Yat-sen University Cancer Center - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Sun_Yat-sen_University_Cancer_Center

WEBSun Yat-sen University Cancer Center ( Chinese: 中山大学肿瘤防治中心;; pinyin: Zhōngshān Dàxué Zhǒngliú Fángzhì Zhōngxīn ), abbreviated as SYSUCC, is a public hospital in Guangzhou, China. It is affiliated with Sun Yat-sen University . The hospital was founded in …

DA: 38 PA: 11 MOZ Rank: 57

Does the Dose of Standard Adjuvant Chemotherapy Affect the
nih.gov

https://pubmed.ncbi.nlm.nih.gov/38628818/

WEB6 days ago · Purpose: Results from studies of extended capecitabine after the standard adjuvant chemotherapy in early stage triple-negative breast cancer (TNBC) were inconsistent, and only low-dose capecitabine from the SYSUCC-001 trial improved disease-free survival (DFS). Adjustment of the conventional adjuvant chemotherapy doses affect the prognosis …

DA: 34 PA: 2 MOZ Rank: 4

Trastuzumab plus endocrine therapy or chemotherapy as first-line
ascopubs.org

https://ascopubs.org/doi/10.1200/JCO.2021.39.15_suppl.1003

WEBMay 28, 2021 · Trastuzumab plus endocrine therapy or chemotherapy as first-line treatment for metastatic breast cancer with hormone receptor-positive and HER2-positive: The sysucc-002 randomized clinical trial. | Journal of Clinical Oncology. Free access. Breast Cancer—Metastatic. May 28, 2021.

DA: 66 PA: 96 MOZ Rank: 99

Effect of Capecitabine Maintenance Therapy Using Lower Dosage ... - PubMed
nih.gov

https://pubmed.ncbi.nlm.nih.gov/33300950/

WEBJan 5, 2021 · Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial. JAMA. 2021 Jan 5;325 (1):50-58. doi: 10.1001/jama.2020.23370. …

DA: 95 PA: 2 MOZ Rank: 98

Alexa Rank

GLOBAL RANK

3,470,909

Alexa Reach

0.0000394400

Page length

N/A

Alexa Rank Country N/A

N/A

Daily Unique Visitors

893

Monthly Unique Visitors

26,803

Vistor via Country

Country lang

Country code

Total visitor

Country

Country code

Total visitor

United States

5,733

Indonesia

4,484

Taiwan

1,458

United Kingdom

1,295

Brazil

1,171

Nigeria

1,024

Egypt

860

Hong Kong

812

Canada

812

Australia

708

Philippines

507

India

493

Malaysia

485

Spain

402

Germany

391

Mexico

375

France

354

Italy

327

Turkey

300

Iraq

273

Thailand

268

Netherlands

257

Israel

255

Cambodia

212

Algeria

163

Ireland

147

Romania

142

Jordan

131

Poland

126

Ghana

121

Argentina

115

South Africa

105

Belgium

Czechia

Ukraine

Japan

Morocco

South Korea

Lebanon

Saudi Arabia

Austria

Hungary

Sweden

Singapore

Pakistan

Bangladesh

Denmark

Greece

Alexa Traffic Graph

Alexa daily traffic trend graph

Alexa Statistics Graph for sysucc.org.cn

Alexa daily pageviews (percent) graph

Alexa Statistics Graph for www.nahklick.de

Alexa daily pageviews per user graph

Alexa time on site (in minutes) graph

Alexa bounce rate (percent) graph

Alexa search visits graph

SEOquake Zone

Title			Tips
Description			Tips
Keywords			Tips
Viewport			Tips
Icon
UTF-8

Mini site formation by Alexa Rank

MOZ Rank

DNS Record

Host	Type	Class	TTL	Extra
sysucc.org.cn	HINFO	IN	3600	Cpu: RFC8482 Os:

Hosting and Whois Zone

IP	14.18.110.149
Domain infomation	Domain Name: sysucc.org.cn ROID: 20090116s10051s24400979-cn Domain Status: ok Registrant: 中山大学肿瘤防治中心 Registrant Contact Email: [email protected] Sponsoring Registrar: 北京新网数码信息技术有限公司 Name Server: ns1.alidns.com Name Server: ns2.alidns.com Registration Time: 2009-01-16 12:00:05 Expiration Time: 2027-01-16 12:00:05 DNSSEC: unsigned

Sysucc.org.cn - Sun Yat-sen University Cancer Center - SYSUCC

Keywords on this domain

sysucc

sysucc-001

sysucc.org.cn

sysucc mail

sysucc.going-link.com

sysucc 002

sysucc-001 trial

Search Results related to sysucc.org.cn on Search Engine

sysucc.org.cn

nih.gov

sysucc.org.cn

jamanetwork.com

ascopubs.org

sysucc.org.cn

wikipedia.org

nih.gov

ascopubs.org

nih.gov

Alexa Rank

Vistor via Country

Alexa Traffic Graph

SEOquake Zone

Mini site formation by Alexa Rank

MOZ Rank

DNS Record

Hosting and Whois Zone